Selective beta blockade improves the outcome of cardiopulmonary resuscitation in a swine model of cardiac arrest


COD: 409-414-min Categorie: ,

Evgenia Theochari, Theodoros Xanthos, Dimitrios Papadimitriou, Theano Demestiha, Nicolas Condilis, Nikolaos Tsirikos-Karapanos, Katerina Tsiftsi, Lila Papadimitriou

Ann. Ital. Chir., 2008; 79: 409-414

La mia nuova descrizione qui!

Price of a print issue €25.00

BACKGROUND AND OBJECTIVES: Epinephrine has been the mainstay drug of choice for cardiac resuscitation for more than 30 years. Its vasopressor effects favoring initial resuscitation point to its β -adrenergic action. However, its β -adrenergic actions may have detrimental effects. The aim of the present experimental study was to evaluate the efficiency of coadministration of Esmolol, an ultra-short-acting beta-blocker, and of epinephrine in a swine model of cardiac arrest.
MATERIALS AND METHODS: Fourteen pigs (19±2 Kg) were anesthetized and instrumented. Ventricular Fibrillation (VF) was produced electrically. After induction of VF, the animals were left untreated for 5 minutes. Animals were randomized into two groups, control and study group. Six animals were used in the control group, and 8 in the study group. The control group received 10 ml of normal saline via a peripheral vein, while the study group received 0.4 mg/kg Esmolol in 10 ml dilution. Epinephrine was administered to all animals after the first unsuccessful defibrillation set, and all animals received standardized Advanced Life Support.
RESULTS: Seven animals (87.5%) restored cardiac rhythm compatible with a pulse in the Esmolol group, compared to 2 animals (33.3%) in the control group (p= 0.018). The average time until restoration of circulation was 16±3.2 minutes in our control group and 12.8±1.4 minutes in Esmolol group (p= 0.059). Coronary perfusion pressure (CPP) was significantly higher in the Esmolol group.
CONCLUSIONS: Esmolol improves significantly the outcome of cardiopulmonary resuscitation and the average time of restoration of circulation, while in the proposed dosage does not alter the CPP at the beginning of CPR. However, it augments CPP from the sixth minute of CPR and afterwards.


Utilizzando il sito, accetti l'utilizzo dei cookie da parte nostra. maggiori informazioni

Questo sito utilizza i cookie per fornire la migliore esperienza di navigazione possibile. Continuando a utilizzare questo sito senza modificare le impostazioni dei cookie o cliccando su "Accetta" permetti il loro utilizzo.